AKITA˛ ®: controlled inhalation - controlled deposition
AKITA˛® is a state of the art controlled breathing device using smart card technology that is ideally suited for use in clinical testing of inhaled pharmaceuticals. AKITA˛® differs from our product AKITA® in that AKITA˛® is equipped with innovative membrane type nebulizers. The incorporation of these aerosol generators allows the device to be much lighter than AKITA® and also more efficient, due to reduced residual volume of drug in the nebulizer.
AKITA Inhalation System. Shown with Pari Nebulizer Handset
The AKITA technology ensures extremely high deposition of inhaled therapeutics and allows specific targeting of different lung regions both in a consistent and reproducible manner. And the smart card technology means that data on compliance and dosing can be recorded automatically for each patient. These properties make AKITA˛® the obvious choice for early clinical trials, in particular for dosing trials of inhaled pharmaceuticals.
For an impression of the working principle of the AKITA˛, please view the AKITA˛ video.
Partnering opportunities:
Activaero would be interested to hear from any medical pharmaceutical or biotechnology company interested in using AKITA˛ ® in clinical trials for inhaled therapeutics or combining it with products on the market to optimize their effectiveness. If you would be interested in finding out more contact us here.